Earnings Call · Q4 FY2024·2025-03-25

Q4 24EPS -26.98%·Rev n/aQ3 24EPS -4.65%·Rev n/aQ2 24EPS -100.00%*·Rev n/aQ1 24EPS -62.50%·Rev n/a⚠ consensus missing

X4 Pharmaceuticals, Inc XFOR

Daniel Ferry — Investor Relations (IR) or Host

Paula Ragan — Chief Executive Officer

Adam Mostafa — Chief Financial Officer

−12.2%1d on move date−12.4% vs SPY3d−8.1%5d−20.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more XFOR calls or request research access.

More XFOR calls Browse calls Request research access